Invention Grant
- Patent Title: Phenoxyquinazoline compounds and their use in treating cancer
-
Application No.: US16608212Application Date: 2018-04-26
-
Publication No.: US11053223B2Publication Date: 2021-07-06
- Inventor: Tudor Grecu , Jason Grant Kettle , Martin John Packer , Stuart Eric Pearson , James Michael Smith
- Applicant: AstraZeneca AB
- Applicant Address: SE Södertälje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Södertälje
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/EP2018/060800 WO 20180426
- International Announcement: WO2018/197643 WO 20181101
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/517 ; A61P35/00 ; A61P35/04 ; C07D405/14
Abstract:
The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation, pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
Public/Granted literature
- US20200223828A1 PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER Public/Granted day:2020-07-16
Information query
